Rifaximin Semi - synthetic Intestinal Antibiotic for Diarrhea and Hepatic Encephalopathy

Basic Information
Place of Origin: China
Brand Name: ChineseHormone
Certification: GMP, ISO 9001, USP
Model Number: CAS 80621-81-4
Minimum Order Quantity: Free samples Available
Price: negotiated
Packaging Details: as your required
Delivery Time: 3-7 working days
Payment Terms: Western Union, MoneyGram, T/T, Bitcoin
Supply Ability: 500-1000 kg / month
MW: 785.879 MF: C43H51N3O11
Appearance: White Or Orange Powder Biological Half-life: 6 Hours
Alias: Xifaxan Shipment:: FedEx, TNT, EMS, DHL.UPS,EUB
Email: Tonyraws810@gmail.com Whatsapp: 86-15871352379
Wickr: Tonyraws
High Light:

pharmaceutical raw material


raw materials for pharmaceutical products

Rifaximin Semi-synthetic Intestinal Antibiotic for Diarrhea  and Hepatic Encephalopathy


Generic Name:Rifaximin

Brand Name:Xifaxan


Drug Class and Mechanism:


Rifaximin is a semi-synthetic intestinal antibiotic used for treating traveler's diarrhea and hepatic encephalopathy. It is derived from rifamycin, a naturally occurring chemical produced by a bacterium called Streptomyces mediterranei.


Rifaximin is active against Escherichia colibacterial strains that cause traveler's diarrhea, preventing growth of the bacteria by preventing them from manufacturing proteins needed for their replication and survival. By suppressing growth of the bacteria, rifaximin reduces symptoms of traveler's diarrhea.


Prescribed for :


Rifaximin is approved for treating patients 12 years or older with traveler's diarrhea caused by Escherichia coli. It also is effective at preventing traveler's diarrhea. It is approved for preventing the recurrence of hepatic encephalopathy in individuals 18 years of age or older. Rifaximin also has been shown to effectively treat non-constipating irritable bowel syndrome.


Rifaximin Semi - synthetic Intestinal Antibiotic for Diarrhea and Hepatic Encephalopathy 0


SIDE EFFECTS: Common side effects associated with rifaximin include:



Mechanism of action


Rifaximin interferes with transcription by binding to the β-subunit of bacterial RNA polymerase. This results in the blockage of the translocation step that normally follows the formation of the first phosphodiester bond, which occurs in the transcription process.


Rifaximin Semi - synthetic Intestinal Antibiotic for Diarrhea and Hepatic Encephalopathy 1



Trade names Xifaxan, Xifaxanta, Normix, Rifagut
CAS Number 80621-81-4
Bioavailability < 0.4%
Excretion Fecal (97%)
Metabolism Hepatic
Biological half-life 6 hours
Routes of administration Oral



​A 2011 study in patients with IBS (without constipation) indicated 11% showed benefits over a placebo.The study was supported by Salix Pharmaceuticals, the patent holder. A 2010 study in patients treated for Hepatic Cirrhosis with hospitalization involving Hepatic encephalopathy resulted in 22% of the rifaxmin treated group experiencing a breakthrough episode of Hepatic encephalopathy as compared to 46% of the placebo group.


The majority patients were also receiving Lactulose therapy for prevention of hepatic encephalopathy in addition to Rifaximin.Rifaximin shows promising results, causing remission in up to 59% of people with Crohn’s disease and up to 76% of people with Ulcerative Colitis.




Any needs, please contact me

Email: tonyraws810@gmail.com

Whatsapp: 86-15871352379

Wickr: tonyraws


Contact Details
Sales Manager

Phone Number : +8613657291547

WhatsApp : +https://api.whatsapp.com/send?phone=8615871352379